Articles by tag: johnson-johnson

Johnson & Johnson spin-off of Kenvue: spin-off and deal

Analysis of the Kenvue spin-off from Johnson & Johnson: declining revenue, Tylenol risks, $48.7 billion deal with Kimberly-Clark. Find out who benefits. Read details.

VELYS without CT: a paradigm shift in robotic orthopedics

Analysis of the VELYS robotic system that eliminates CT in joint replacement. Why it threatens Stryker Mako and how the Asian market is changing. Read.